Related Experiment Video

Updated: Apr 21, 2026

Assessing Endothelial Vasodilator Function with the Endo-PAT 2000
07:46

Assessing Endothelial Vasodilator Function with the Endo-PAT 2000

Published on: October 15, 2010

44.7K

Homocysteine, Paraoxonase-1 and Vascular Endothelial Dysfunction: Omnibus viis Romam Pervenitur

Esin Eren1, Hamit Yasar Ellidag2, Ozgur Aydin3

  • 1Laboratory of Atatürk Hospital , Antalya/Turkey .

Journal of Clinical and Diagnostic Research : JCDR
|November 12, 2014
PubMed

Insights

Homocysteine (Hcy) may promote atherosclerosis by interacting with paraoxonase 1 (PON1), an antioxidant enzyme. Understanding this link is crucial for developing new treatments for cardiovascular diseases.

Area of Science:

  • Biochemistry
  • Cardiovascular Science
  • Molecular Biology

Background:

  • Hyperhomocysteinemia is linked to atherosclerosis through oxidative stress, lipid metabolism changes, and thrombosis.
  • Endothelial dysfunction is a central factor in atherogenesis, especially with cardiovascular risk factors.
  • The precise mechanisms by which homocysteine (Hcy) contributes to atherosclerosis remain unclear.

Purpose of the Study:

  • To explore the relationship between homocysteine (Hcy) and the antioxidant enzyme paraoxonase 1 (PON1) in the context of atherosclerosis.
  • To investigate the potential role of Hcy-PON1 interactions in endothelial dysfunction and atherogenesis.

Main Methods:

  • Review of existing literature on homocysteine, paraoxonase 1, and atherosclerosis.
  • Analysis of studies investigating the correlation between PON1 activity/levels and Hcy in cardiovascular disease.
  • Examination of the biochemical properties of PON1 and its natural substrates, including Hcy-thiolactone.

Main Results:

  • Few studies have directly correlated PON1 and Hcy levels in atherosclerosis.
  • Both PON1 and Hcy are implicated in diseases associated with endothelial dysfunction.
  • Hcy-thiolactone is a naturally occurring substrate for paraoxonases.

Conclusions:

  • The interaction between homocysteine (Hcy) and paraoxonase 1 (PON1) is a likely mediator of Hcy's role in atherosclerotic disease.
  • Further research is needed to elucidate the specific molecular mechanisms of Hcy-PON1 interaction in atherogenesis.
  • Targeting the Hcy-PON1 pathway may offer novel therapeutic strategies for preventing or treating atherosclerosis.

Keywords:
AtherosclerosisEndothelial dysfunctionHomocysteineNitric oxideParaoxonase

More Related Videos

Using En Face Immunofluorescence Staining to Observe Vascular Endothelial Cells Directly06:09

Using En Face Immunofluorescence Staining to Observe Vascular Endothelial Cells Directly

Published on: August 20, 2019

17.6K
Author Spotlight: A Pharmacodissection Approach to Uncover Mechanisms in Cardiovascular Disease Risk Populations08:21

Author Spotlight: A Pharmacodissection Approach to Uncover Mechanisms in Cardiovascular Disease Risk Populations

Published on: July 21, 2023

2.2K

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
789
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
4.0K
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
1.7K
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.6K
Vascular Spasm01:16

Vascular Spasm

The vascular phase, also known as vasospasm, is the initial stage of hemostasis, crucial for preventing excessive bleeding when a blood vessel is injured. After a vessel is cut, nerves in the damaged area trigger pain and other sensory impulses. Simultaneously, the smooth muscles in the vessel wall contract, resulting in a vascular spasm. This contraction reduces the vessel's diameter at the injury site, slowing or stopping blood loss through the vessel wall. Vascular spasms typically last...
5.2K
Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...
7.0K